135 related articles for article (PubMed ID: 24649554)
1. [Advances in uveal melanoma].
Piperno-Neumann S; Desjardins L
Rev Prat; 2014 Jan; 64(1):83-4. PubMed ID: 24649554
[No Abstract] [Full Text] [Related]
2. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma.
Eldh M; Olofsson Bagge R; Lässer C; Svanvik J; Sjöstrand M; Mattsson J; Lindnér P; Choi DS; Gho YS; Lötvall J
BMC Cancer; 2014 Dec; 14():962. PubMed ID: 25510783
[TBL] [Abstract][Full Text] [Related]
3. The newest treatments for uveal melanoma.
Luke JJ
Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
[No Abstract] [Full Text] [Related]
4. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
5. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
6. Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T
Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
[TBL] [Abstract][Full Text] [Related]
7. Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis.
Grossniklaus HE
Ophthalmology; 2019 Apr; 126(4):483-487. PubMed ID: 30910033
[No Abstract] [Full Text] [Related]
8. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
9. Uveal melanoma: implications of tumor doubling time.
Singh AD
Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
[No Abstract] [Full Text] [Related]
10. New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma.
Barker CA; Salama AK
J Natl Compr Canc Netw; 2018 May; 16(5S):646-650. PubMed ID: 29784747
[TBL] [Abstract][Full Text] [Related]
11. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
Li YP
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
[TBL] [Abstract][Full Text] [Related]
12. Screening for uveal melanoma metastasis. Literature review.
Missotten GS; Keunen JE
Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
[TBL] [Abstract][Full Text] [Related]
13. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
14. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
15. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
[No Abstract] [Full Text] [Related]
16. Invited commentary. Uveal melanoma: implications of tumor doubling time.
O'Brien J
Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
[No Abstract] [Full Text] [Related]
17. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
[No Abstract] [Full Text] [Related]
18. Latest developments in the biology and management of uveal melanoma.
Patel SP
Curr Oncol Rep; 2013 Dec; 15(6):509-16. PubMed ID: 24122445
[No Abstract] [Full Text] [Related]
19. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
[TBL] [Abstract][Full Text] [Related]
20. [MBD4 inactivation induces a new mutator phenotype in cancers].
Rodrigues M; Mobuchon L; Houy A; Derrien AC; Stern MH
Bull Cancer; 2018 Sep; 105(9):736-737. PubMed ID: 30032956
[No Abstract] [Full Text] [Related]
[Next] [New Search]